
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of SpyGlass Pharma (NASDAQ:SGP) through any online brokerage.
Other companies in SpyGlass Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
SpyGlass Pharma has a consensus price target of $44.00.
The stock price for SpyGlass Pharma (NASDAQ: SGP) is $24.78 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for SpyGlass Pharma.
SpyGlass Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for SpyGlass Pharma.
SpyGlass Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing...